Tapewire

Nasdaq · USD

DRMA

Dermata Therapeutics, Inc.

Export transactions ↓
Tapewire entity
8182
SEC CIK
0001853816
Parsed reports
102

Last 12 months

Inside the activity.

1 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 13, 2025 Filed Jan 14, 2025 23:50 UTC
PROEHL GERALD TDirector · President, CEO and Chairman
GrantStock Option (right to buy) · Derivative 45,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001654954-25-000398 · section16.xml · derivative · entry 1

PROEHL GERALD T · CIK 0001279191 · Director · President, CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2035-01-12

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 23:50 UTC
FISHER MARYDirector
GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001654954-25-000400 · section16.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2035-01-12

F1 · derivative.exercise_date: The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 23:50 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001654954-25-000397 · section16.xml · derivative · entry 1

Mento Steven J · CIK 0001324466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2035-01-12

F1 · derivative.exercise_date: The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 23:49 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001654954-25-000396 · section16.xml · derivative · entry 1

Scott Kathleen D. · CIK 0001794284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2035-01-12

F1 · derivative.exercise_date: The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 21:00 UTC
HALE DAVID FDirector
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000293 · section16.xml · derivative · entry 1

HALE DAVID F · CIK 0001024004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 21:01 UTC
Nardo Christopher J.Senior VP, CDO
GrantStock Option (right to buy · Derivative 50,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000295 · section16.xml · derivative · entry 1

Nardo Christopher J. · CIK 0001870247 · Senior VP, CDO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:00 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000291 · section16.xml · derivative · entry 1

Van Hoose Kyri K. · CIK 0001860885 · SVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:04 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000300 · section16.xml · derivative · entry 1

Mento Steven J · CIK 0001324466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:02 UTC
PROEHL GERALD TDirector · President, CEO and Chairman
GrantStock Option (right to buy) · Derivative 125,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000299 · section16.xml · derivative · entry 1

PROEHL GERALD T · CIK 0001279191 · Director · President, CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12-month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12-month anniversary of the grant date.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:02 UTC
FISHER MARYDirector
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000298 · section16.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:01 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000297 · section16.xml · derivative · entry 1

Scott Kathleen D. · CIK 0001794284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:01 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000296 · section16.xml · derivative · entry 1

Sandler Andrew Seth · CIK 0001596060 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:01 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000294 · section16.xml · derivative · entry 1

WIERENGA WENDELL · CIK 0001239956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:00 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000292 · section16.xml · derivative · entry 1

Bradrick Brittany · CIK 0001904176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

Read SEC document
January 04, 2024 Filed Jan 6, 2024 02:00 UTC
Bedoya-Toro Munera Maria ESVP, Regulatory Affairs
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001654954-24-000290 · section16.xml · derivative · entry 1

Bedoya-Toro Munera Maria E · CIK 0001400048 · SVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12-month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12-month anniversary of the grant date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:06 UTC
Nardo Christopher J.Senior VP, CDO
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001654954-23-000146 · section16.xml · derivative · entry 1

Nardo Christopher J. · CIK 0001870247 · Senior VP, CDO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-01-02

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001654954-23-000147 · section16.xml · derivative · entry 1

Van Hoose Kyri K. · CIK 0001860885 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-01-02

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Bedoya-Toro Munera Maria ESVP, Regulatory Affairs
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001654954-23-000148 · section16.xml · derivative · entry 1

Bedoya-Toro Munera Maria E · CIK 0001400048 · SVP, Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2033-01-02

F1 · derivative.exercise_date: The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
October 06, 2022 Filed Oct 7, 2022 17:06 UTC
HALE DAVID FDirector
GrantCommon Stock 30,155 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-013528 · section16.xml · nonDerivative · entry 1

HALE DAVID F · CIK 0001024004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,720

F1 · date: On October 6, 2022, the Reporting Person was granted 30,155 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
October 06, 2022 Filed Oct 7, 2022 21:06 UTC GrantCommon Stock 9,810 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-013529 · section16.xml · nonDerivative · entry 1

Bradrick Brittany · CIK 0001904176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,443

F1 · date: On October 6, 2022, the Reporting Person was granted 9,810 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
October 06, 2022 Filed Oct 7, 2022 21:06 UTC GrantCommon Stock 10,120 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-013530 · section16.xml · nonDerivative · entry 1

Sandler Andrew Seth · CIK 0001596060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,184

F1 · date: On October 6, 2022, the Reporting Person was granted 10,120 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
October 06, 2022 Filed Oct 7, 2022 21:05 UTC
FISHER MARYDirector
GrantCommon Stock 9,810 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-013527 · section16.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,443

F1 · date: On October 6, 2022, the Reporting Person was granted 9,810 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
October 06, 2022 Filed Oct 7, 2022 21:05 UTC GrantCommon Stock 11,359 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-013526 · section16.xml · nonDerivative · entry 1

Scott Kathleen D. · CIK 0001794284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,145

F1 · date: On October 6, 2022, the Reporting Person was granted 11,359 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
October 06, 2022 Filed Oct 7, 2022 21:05 UTC GrantCommon Stock 20,654 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-013525 · section16.xml · nonDerivative · entry 1

WIERENGA WENDELL · CIK 0001239956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,398

F1 · date: On October 6, 2022, the Reporting Person was granted 20,654 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 16:10 UTC
HALE DAVID FDirector
GrantCommon Stock 26,441 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-009455 · section16.xml · nonDerivative · entry 1

HALE DAVID F · CIK 0001024004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,565

F1 · shares: On July 7, 2022, the Reporting Person was granted 26,441 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:10 UTC GrantCommon Stock, par value $0.0001 per share 8,874 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-009457 · section16.xml · nonDerivative · entry 1

Sandler Andrew Seth · CIK 0001596060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,064

F1 · shares: On July 7, 2022, the Reporting Person was granted 8,874 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:10 UTC GrantCommon Stock, par value $0.0001 per share 8,602 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-009456 · section16.xml · nonDerivative · entry 1

Bradrick Brittany · CIK 0001904176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,633

F1 · shares: On July 7, 2022, the Reporting Person was granted 8,602 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:10 UTC GrantCommon Stock 9,960 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-009454 · section16.xml · nonDerivative · entry 1

Scott Kathleen D. · CIK 0001794284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,786

F1 · shares: On July 7, 2022, the Reporting Person was granted 9,960 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:10 UTC GrantCommon Stock 18,110 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-009453 · section16.xml · nonDerivative · entry 1

WIERENGA WENDELL · CIK 0001239956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,744

F1 · shares: On July 7, 2022, the Reporting Person was granted 18,110 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:10 UTC
FISHER MARYDirector
GrantCommon Stock 8,602 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-009452 · section16.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,633

F1 · shares: On July 7, 2022, the Reporting Person was granted 8,602 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
July 01, 2022 Filed Jul 7, 2022 20:04 UTC
Nardo Christopher J.Senior VP, CDO
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $0.51 $0.00
Disclosure

SEC source: 0001654954-22-009392 · section16.xml · derivative · entry 1

Nardo Christopher J. · CIK 0001870247 · Senior VP, CDO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-06-30

F1 · derivative.exercise_date: The option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 19:12 UTC
HALE DAVID FDirector
GrantCommon Stock 15,466 $0.00 $0.00
Disclosure

SEC source: 0000905718-22-000562 · dermata_fm4apr72022.xml · nonDerivative · entry 1

HALE DAVID F · CIK 0001024004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,124

F1 · shares: On April 7, 2022, the Reporting Person was granted 15,466 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 23:26 UTC GrantCommon Stock 10,593 $0.00 $0.00
Disclosure

SEC source: 0000905718-22-000572 · dermata_fm4apr72022.xml · nonDerivative · entry 1

WIERENGA WENDELL · CIK 0001239956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,471

F1 · shares: On April 7, 2022, the Reporting Person was granted 10,593 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 23:19 UTC
FISHER MARYDirector
GrantCommon Stock 5,031 $0.00 $0.00
Disclosure

SEC source: 0000905718-22-000570 · dermata_fm4apr72022.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,031

F1 · shares: On April 7, 2022, the Reporting Person was granted 5,031 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 23:17 UTC GrantCommon Stock 5,826 $0.00 $0.00
Disclosure

SEC source: 0000905718-22-000568 · dermata_fm4apr72022.xml · nonDerivative · entry 1

Scott Kathleen D. · CIK 0001794284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,826

F1 · shares: On April 7, 2022, the Reporting Person was granted 5,826 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 23:15 UTC GrantCommon Stock, par value $0.0001 per share 5,190 $0.00 $0.00
Disclosure

SEC source: 0000905718-22-000566 · dermata_fm4apr72022.xml · nonDerivative · entry 1

Sandler Andrew Seth · CIK 0001596060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,190

F1 · shares: On April 7, 2022, the Reporting Person was granted 5,190 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 23:13 UTC GrantCommon Stock, par value $0.0001 per share 5,031 $0.00 $0.00
Disclosure

SEC source: 0000905718-22-000564 · dermata_fm4apr72022.xml · nonDerivative · entry 1

Bradrick Brittany · CIK 0001904176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,031

F1 · shares: On April 7, 2022, the Reporting Person was granted 5,031 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

Read SEC document
January 12, 2022 Filed Jan 14, 2022 22:10 UTC GrantStock Option (right to Buy) · Derivative 10,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000905718-22-000113 · dermata_fm4jan122022.xml · derivative · entry 1

Bradrick Brittany · CIK 0001904176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-01-11

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on January 12, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 19:08 UTC
HALE DAVID FDirector
GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000048 · dermata_fm4jan32022.xml · derivative · entry 1

HALE DAVID F · CIK 0001024004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 19:22 UTC
Nardo Christopher J.Senior VP, Development
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000052 · dermata_fm4jan32022.xml · derivative · entry 1

Nardo Christopher J. · CIK 0001870247 · Senior VP, Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:15 UTC
Van Hoose Kyri K.SVP, Chief Financial Officer
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000050 · dermata_fm4jan32022.xml · derivative · entry 1

Van Hoose Kyri K. · CIK 0001860885 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:24 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000054 · dermata_fm4jan32022.xml · derivative · entry 1

Sandler Andrew Seth · CIK 0001596060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:07 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000046 · dermata_fm4jan32022.xml · derivative · entry 1

WIERENGA WENDELL · CIK 0001239956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:05 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000044 · dermata_fm4jan32022.xml · derivative · entry 1

Scott Kathleen D. · CIK 0001794284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:03 UTC GrantStock Option (right to Buy) · Derivative 5,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000042 · dermata_fm4jan32022.xml · derivative · entry 1

Mento Steven J · CIK 0001324466 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:01 UTC
FISHER MARYDirector
GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000040 · dermata_fm4jan32022.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:59 UTC
Bedoya-Toro Munera Maria ESenior Vice President
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000038 · dermata_fm4jan32022.xml · derivative · entry 1

Bedoya-Toro Munera Maria E · CIK 0001400048 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:58 UTC
PROEHL GERALD TDirector · President, CEO and Chairman · 10% owner
GrantStock Option (right to buy) · Derivative 57,859 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0000905718-22-000036 · dermata_fm4jan32022.xml · derivative · entry 4

PROEHL GERALD T · CIK 0001279191 · Director · President, CEO and Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,859

Underlying: Common Stock · 57,859 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:58 UTC
PROEHL GERALD TDirector · President, CEO and Chairman · 10% owner
GrantStock Option (right to buy) · Derivative 42,141 $0.00 Strike: $2.07 $0.00
Disclosure

SEC source: 0000905718-22-000036 · dermata_fm4jan32022.xml · derivative · entry 3

PROEHL GERALD T · CIK 0001279191 · Director · President, CEO and Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,141

Underlying: Common Stock · 42,141 shares

Expires 2027-01-02

F1 · derivative.exercise_date: The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:58 UTC
PROEHL GERALD TDirector · President, CEO and Chairman · 10% owner
GrantStock Option (right to buy) · Derivative 4,517 $0.00 Strike: $2.07 $0.00
Disclosure

SEC source: 0000905718-22-000036 · dermata_fm4jan32022.xml · derivative · entry 2

PROEHL GERALD T · CIK 0001279191 · Director · President, CEO and Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2027-01-02

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.